Jahn Ferenc Dél-Pesti Kórház

Budapest 1204

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting, NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO)

Studies at this site

• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early
• Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) — Completed